The Flux Symposium was a one-day event to discuss the motivations for and consequences of drug use among gay and bisexual men.
The Flux Study is Australia’s first and only longitudinal study of drug use among gay and bisexual men. The study uses a unique and innovative online methodology developed specifically to identify factors that predict initiation of and changes in patterns of drug use over time.
The symposium discussed what Flux can tell us about the predictors and consequences of drug use and explored the issues surrounding gay and bisexual men’s beliefs and behaviours concerning drugs.
The Honourable Justice Michael Kirby opened the symposium. Speakers included Associate Professor Garrett Prestage, Dr Jeff Jin, and Mr Mo Hammoud, with guest speakers Associate Professor Martin Holt and Associate Professor Adam Bourne (UK). This symposium was hosted by Dr Denton Callander.
CLICK HERE for full agenda details.
The Honourable Justice Michael Kirby: Welcome address
Associate Professor Martin Holt: Prevalence and trends in drug use among gay and bisexual men in Australia
Associate Professor Garrett Prestage: Rationale for the Flux Study
Mo Hammoud: Building and maintaining a cohort study of drug use among gay men
Dr Jeff Jin: Baseline prevalence of licit and illicit drug use
Mo Hammoud: Characteristics associated with use of erectile dysfunction medication, crystal methamphetamine, and GHB
Brendan Jacka: Latent class analysis of crystal methamphetamine
Jack Bradley: Harms associated with drug use among gay men
Dr Jeff Jin: Initiation and cessation of drug use over first year of follow-up
Mo Hammoud: What factors predict the initiation and cessation of crystal methamphetamine and GHB
Associate Professor Garrett Prestage: What factors predict the initiation and cessation of PrEP
Associate Professor Garrett Prestage: Attitudes and beliefs about drug use among gay men
Brent Mackie: Implications for policy and practice in a community setting
Panel discussion: Looking to the future: What needs to be done and what don’t we know?